• LAST PRICE
    178.85
  • TODAY'S CHANGE (%)
    Trending Down-0.49 (-0.27%)
  • Bid / Lots
    178.70/ 1
  • Ask / Lots
    178.99/ 3
  • Open / Previous Close
    183.82 / 179.33
  • Day Range
    Low 178.26
    High 186.50
  • 52 Week Range
    Low 76.59
    High 331.68
  • Volume
    1,256,921
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 179.33
TimeVolumeNVAX
09:32 ET70466182.86
09:34 ET28318183.44
09:36 ET52184185.33
09:38 ET25358184
09:39 ET39016185.8
09:41 ET29102185.53
09:43 ET10779184.729
09:45 ET8704183.6501
09:48 ET6422184.44
09:50 ET11562183.7
09:52 ET16019184.22
09:54 ET16191182.8
09:56 ET19355184.2639
09:57 ET5050184.675
09:59 ET19355185.15
10:01 ET17399185.98
10:03 ET11346185.065
10:06 ET17275184.5
10:08 ET13055183.9
10:10 ET5450184
10:12 ET13597184.4299
10:14 ET13564183.9291
10:15 ET11327183.43
10:17 ET34077181.5
10:19 ET23429181.585
10:21 ET15763180.92
10:24 ET13840180.68
10:26 ET10348180.9696
10:28 ET16820181.1257
10:30 ET10493181.4
10:32 ET16773181.26
10:33 ET9038181.245
10:35 ET11274180.84
10:37 ET5829180.91
10:39 ET9734180.7025
10:42 ET9392180.5448
10:44 ET5464180.6035
10:46 ET3810180.58
10:48 ET4167180.92
10:50 ET4657180.81
10:51 ET2960180.59
10:53 ET5031180.8796
10:55 ET5441180.53
10:57 ET46596180.19
11:00 ET12224179.74
11:02 ET11871179.28
11:04 ET4982179.3589
11:06 ET12215179.52
11:08 ET8310178.625
11:09 ET8093178.8651
11:11 ET7089178.9737
11:13 ET8500178.87
11:15 ET7105178.81
11:18 ET2404178.8
11:20 ET10415178.77
11:22 ET18277179.887
11:24 ET3044179.51
11:26 ET6566179.535
11:27 ET6415179.08
11:29 ET4523179.625
11:31 ET4571178.88
11:33 ET6547178.81
11:36 ET11034178.648
11:38 ET6159178.9482
11:40 ET9852178.7152
11:42 ET3830178.53
11:44 ET2856178.845
Data delayed at least 15 minutes.

Jul 13, 2021

3:50PM ET on Tuesday Jul 13, 2021 by Thomson Reuters

Jul 8, 2021

8:40PM ET on Thursday Jul 08, 2021 by Thomson Reuters

8:11PM ET on Thursday Jul 08, 2021 by Thomson Reuters
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNVAX
Novavax Inc
13.3B
-19.3x
---
United StatesMRVI
Maravai LifeSciences Holdings Inc
11.3B
16.5x
---
United StatesGH
Guardant Health Inc
11.1B
-33.7x
---
United StatesZLAB
Zai Lab Ltd
12.0B
0.0x
---
United StatesCVAC
CureVac NV
9.2B
0.0x
---
United StatesNTLA
Intellia Therapeutics Inc
10.2B
-56.6x
---
As of 2021-08-02

Company Information

Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates to respond to both known and newly emerging diseases. The Company's product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza and the Ebola virus (EBOV). The Company's lead adjuvant for human applications, Matrix-M, is in a Phase I/II clinical trial for pandemic influenza H7N9 vaccine candidate. It is also testing Matrix-M in conjunction with its EBOV vaccine candidate in a Phase I clinical trial. It is developing additional pre-clinical stage programs in a range of infectious diseases, including Middle East respiratory syndrome (MERS).

Contact Information

Headquarters
21 Firstfield RdGAITHERSBURG, MD, United States 20878-1757
Phone
240-268-2000
Fax
302-655-5049

Executives

Independent Chairman of the Board
James Young
President, Chief Executive Officer, Director
Stanley Erck
Interim Chief Financial Officer, Executive Vice President, Chief Commercial Officer and Chief Business Officer
John Trizzino
President, Research and Development
Gregory Glenn
Chief Operating Officer, Executive Vice President
Rick Crowley

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$13.3B
Revenue (TTM)
$919.5M
Shares Outstanding
74.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.59
EPS
$-9.25
Book Value
$8.84
P/E Ratio
-19.3x
Price/Sales (TTM)
14.5
Price/Cash Flow (TTM)
---
Operating Margin
-65.52%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.